Dichlorodiphenyldichloroethylene Exposure Reduces R-Gcs Via Suppressed Nrf2 in HepG2 Cells
Xiaoting Jin,Li Song,Zhuoyu Li,Ian P. Newton,Meirong Zhao,Weiping Liu
DOI: https://doi.org/10.1002/tox.22049
IF: 4.109
2014-01-01
Environmental Toxicology
Abstract:p,p-dichlorodiphenyldichloroethylene (p,p-DDE), the major isomer of persistent 1,1-Bis(4-chlorophenyl)-2,2,2-trichloroethane metabolite, is highly associated with the risk of liver cancer. -glutamyl-cysteine synthetase (-GCS), which is the rate-limiting enzyme of glutathione (GSH) biosynthesis and an important scavenger of reactive oxygen species (ROS), is considered as a potential therapeutic target for many cancers. However, the association between the body burden of p,p-DDE and -GCS has not been fully established. Here, we indicated that low doses of p,p-DDE exposure promoted the proliferation and decreased -GCS activity of HepG2 cells in a dose- and time-dependent manner. In addition, p,p-DDE elevated ROS content and attenuated glutathione peroxidase activity. This was accompanied with inhibitions of NF-E2-related factor 2 (Nrf2) at the mRNA and protein levels. ROS inhibitor supplement could significantly reverse these effects. Moreover, the addition of the proteasome inhibitor, MG132, strongly reversed the p,p-DDE-reduced Nrf2 expression and -GCS activity. Consistently, GSH content was in line with the alteration of -GCS. Collectively, the results indicate that p,p-DDE treatment downregulates -GCS activity in HepG2 cells by inducing ROS-mediated Nrf2 loss. (c) 2014 Wiley Periodicals, Inc. Environ Toxicol 31: 350-359, 2016.